Relevant bibliographies by topics / Herpes simplex virus

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Herpes simplex virus'

Author: Grafiati
Published: 4 June 2021
Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Herpes simplex virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Herpes simplex virus"

1

Waggoner-Fountain, L. A., and L. B. Grossman. "Herpes Simplex Virus." Pediatrics in Review 25, no. 3 (March 1, 2004): 86–93. http://dx.doi.org/10.1542/pir.25-3-86.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Taylor, Travis, J. "Herpes Simplex Virus." Frontiers in Bioscience 7, no. 1-3 (2002): d752. http://dx.doi.org/10.2741/taylor.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Landy, Helain J., and John H. Grossman. "Herpes Simplex Virus." Obstetrics and Gynecology Clinics of North America 16, no. 3 (September 1989): 495–515. http://dx.doi.org/10.1016/s0889-8545(21)00405-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hönemann, M. "Herpes-simplex-Virus." DMW - Deutsche Medizinische Wochenschrift 147, no. 08 (April 2022): 495–96. http://dx.doi.org/10.1055/a-1710-0258.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Seidle, Michael E. "Herpes simplex virus." Postgraduate Medicine 93, no. 4 (March 1993): 308–9. http://dx.doi.org/10.1080/00325481.1993.11701655.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Klapper, P. E., and G. M. Cleator. "Herpes simplex Virus." Intervirology 40, no. 2-3 (1997): 62–71. http://dx.doi.org/10.1159/000150534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Turrentine, Mark, and Bernard Gonik. "Herpes simplex virus." Current Opinion in Obstetrics and Gynecology 6, no. 4 (August 1994): 377–82. http://dx.doi.org/10.1097/00001703-199408000-00016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

KHAIRALLAH, M., S. ATTIA, and I. NAHDI. "Herpes simplex virus." Acta Ophthalmologica 89, s248 (September 2011): 0. http://dx.doi.org/10.1111/j.1755-3768.2011.4441.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Riley, Laura E. "Herpes simplex virus." Seminars in Perinatology 22, no. 4 (August 1998): 284–92. http://dx.doi.org/10.1016/s0146-0005(98)80017-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Herpes simplex virus." Nursing 30, no. 3 (March 2000): 30. http://dx.doi.org/10.1097/00152193-200030030-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Herpes simplex virus"

1

Nahum, Joseph. "Thérapeutique des infections à Herpes simplex virus." Paris 5, 1999. http://www.theses.fr/1999PA05P200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ingemarson, Rolf. "Herpes simplex ribonucleotide reductase." Doctoral thesis, Umeå universitet, Institutionen för medicinsk kemi och biofysik, 1989. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-101352.

Full text
Abstract:
In all bacterial, plant and animal cells, as well as in many viruses, genetic information resides in DNA (deoxyribonucleic acid). Replication of DNA is essential for proliferation, and DNA-containing viruses (such as herpesviruses) must carry out this process within the mammalian cells they infect. The enzyme ribonucleotide reductase catalyzes the first unique step leading to the production of the four deoxy-ribonucleotides used to make DNA. Each deoxyribonucleotide is produced by reduction of the corresponding ribonucleotide. After infection of a mammalian cell with herpes simplex virus (HSV) a new ribonucleotide reductase activity appears, which is distinct from the mammalian enzyme activity. This is due to induction of a separate, virally-encoded ribonucleotide reductase. Two monoclonal antibodies were raised against HSV (type 1) ribonucleotide reductase, and were found to bind but not neutralize its enzyme activity. One antibody recognized a larger (140 kD) protein and the other a smaller (40 kD) protein, suggesting the HSV 1 ribonucleotide reductase had a heterodimeric composition similar to that found in many other organisms. The 140 kD protein was sequentially degraded to 110 kD, 93 kD and 81 kD proteins by a host (Vero) cell-specific serine protease. Of these different proteolytic products, at least the 93 kD residue was enzymatically active, suggesting that part of the 140 kD protein may have functions unrelated to ribonucleotide reduction. The 140 and 40 kD proteins bound tightly to each other in a complex of the a2ß2 type, as shown by analytical glycerol gradient centrifugation. An assay system for functional small and large subunits of HSV 1 ribonucleotide reductase was developed, using two temperaturesensitive mutant viruses, defective in either the large (tsl207) or small (tsl222) subunits. Active holoenzyme was reconstituted both in vitro, by mixing extracts from cells infected with either mutant, and in vivo by coinfection of cells with both mutants. The gene encoding the small subunit of HSV 1 ribonucleotide reductase was cloned into an expression plasmid under control of a tac promoter. The recombinant protein was purified to homogeneity from extracts of transfected E. coli, and was active when combined with large subunit, as provided by extracts of tsl222- infected hamster (BHK) cells. The protein contained a novel tyrosyl free radical that spectroscopically resembled, but was distinguishable from, the active-site free radical found in either the E. coli or mammalian small subunits of ribonucleotide reductase. The gene encoding the large subunit of HSV 1 ribonucleotide reductase was also expressed in E. coli, using similar techniques. The recombinant large subunit was immunoprecipitated from extracts of transfected bacteria, and showed weak activity when combined with small subunit, provided by extracts of tsl20-infected hamster (BHK) cells.

Diss. (sammanfattning) Umeå : Umeå universitet, 1989, härtill 4 uppsatser.


digitalisering@umu
APA, Harvard, Vancouver, ISO, and other styles
3

Turner, Angelina. "Herpes simplex virus induced membrane fusion." Thesis, University of Cambridge, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.625097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bajric, Amina. "Validering av Varicella Zoster virus och Herpes Simplex virus." Thesis, Malmö universitet, Fakulteten för hälsa och samhälle (HS), 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-24474.

Full text
Abstract:
Syftet med denna valideringsstudie är att värdera lämpligheten att överföra den manuella analysen av aktuell infektion av Varicella Zoster Virus (aVZV IgM) och Herpes Simplex Virus (aHSV IgM) med SIEMENS Enzygnost® till en av de automatiserade analysinstrumenten EUROIMMUN Analyzer I (ELISA) eller DiaSorin LIAISON® XL. Arbetet utfördes på Klinisk Mikrobiologi i Lund. Konsekutiva serumprover för VZV IgM (n=108) och för HSV IgM (n=116) från det vardagliga flödet analyserades, tillsammans med 10 PCR- eller serokonversion-konfirmerade positiva serumprover av primär infektion VZV och HSV samt 10 positiva för reaktiverad infektion av VZV och HSV. Utöver det användes 10 serumprover konfirmerade positiva för Cytomegalovirus (CMV) respektive 10 för Epstein-Barr Virus (EBV) för att testa korsreaktionen metoderna emellan. Resultatet från VZV-valideringen i Analyzer I samt LIAISON® XL gav en överensstämmelse på 93% respektive 94% av de konsekutiva proverna, 71% respektive 86% av de primärinfekterade proverna och 75% respektive 58% av de reaktiverade proverna, samt en korsreaktivitet (positiva och gränsvärden) på totalt 33% respektive 20% av proverna. Resultatet från HSV-valideringen i Analyzer I samt LIAISON® XL gav en överensstämmelse på 84% respektive 87% av de konsekutiva proverna, 82% respektive 18% av de primärinfekterade proverna och 40% respektive 10% av de reaktiverade proverna, samt en korsreaktivitet (positiva och gränsvärden) på totalt 67% respektive 47% av proverna. Enligt rekommendation efter utförandet av denna studie så bör analysen av HSV IgM uteslutas från båda automatiserade metoder medan VZV IgM bör kontrolleras något ytterligare i Analyzer I, med förhoppning om att denna metod kan vara känsligare.
The approach of this validation study is to evaluate the adequacy for transferring the manual analysis method of ongoing infection of Varicella Zoster Virus (aVZV IgM) and Herpes Simplex Virus (aHSV IgM) with SIEMENS Enzygnost® to one of the automated instruments EUROIMMUN Analyzer I (ELISA) or DiaSorin LIAISON® XL. The study was carried out at Clinical Microbiology in Lund. Consecutive serum samples for VZV IgM (n=108) and HSV IgM (n=116) from the daily local flow of tests were analyzed, along with 10 positive for primary infection of VZV and HSV, confirmed by PCR or seroconversion, and 10 with reactivated infection of VZV and HSV. Beyond those, 10 serum samples confirmed positive for Cytomegalovirus (CMV) respectively 10 for Epstein-Barr Virus (EBV) to test the cross-reaction between the three methods. The results from the validation of VZV in Analyzer I and LIAISON® XL gave an agreement of 93% and 94% respectively in the consecutive tests, 71% and 86% respectively in the primary infected tests and 75% and 58% respectively in the reactivated tests, and also a cross-reactivity (both positive and in between-values) at a total of 33% respectively 20% of the tests. The results from the validation of HSV in Analyzer I and LIAISON® XL gave an agreement of 84% and 87% respectively in the consecutive tests, 82% and 18% respectively in the primary infected tests and 40% and 10% respectively in the reactivated tests, and also a cross-reactivity (both positive and in between-values) at a total of 67% respectively 47% of the tests. According recommendations after the performance of this study, the analysis of HSV IgM should be excluded from both of the automated methods while VZV IgM should be controlled further in Analyzer I, with hopes that this new method could be more sensitive.
APA, Harvard, Vancouver, ISO, and other styles
5

Atfield, Rachel Sarah. "Herpes simplex virus glycoprotein-mediated membrane fusion." Thesis, University of Cambridge, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615860.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Barr, Beverly Bell Brown. "Molecular epidemiology of herpes simplex virus infections." Thesis, University of Edinburgh, 1987. http://hdl.handle.net/1842/19152.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Graham, Richard Peter. "Purification of glycoproteins from herpes simplex virus." Master's thesis, University of Cape Town, 1985. http://hdl.handle.net/11427/25694.

Full text
Abstract:
The aim of this work was to purify type-specific glycoproteins from herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) for diagnostic use. The most likely candidate for a type-specific glycoprotein of HSV-1 is glycoprotein C (gC), although it has recently been shown to contain some type-common antigenic determinants. HSV-1 and HSV-2 were produced in BHK-21 cells and labelled with either (³H)-glucosamine ((³H)-gln) or a mixture of (¹⁴C)-amino acids ((¹⁴C)-aa). Analysis of the radiolabelled products by analytical sodium dodecyl sulphate polyacrylamide gel electrophoresis (SOS-PAGE) and autoradiography revealed that in the HSV-1 infected cells the radiolabelled components were incorporated into viral specific proteins only, whereas in the HSV-2 infected cells they were incorporated into host cell proteins as well as viral proteins. Preparative polyacrylamide gel electrophoresis (Prep-PAGE) was used as an initial step in separating HSV-1 infected cell proteins labelled with (³H)-gln. Two cycles of Prep-PAGE were sufficient to produce solutions containing either glycoprotein B ( gB) or glyco- protein C (gC), which were free of other HSV-1 glycoproteins. However, these solutions still contained a number of non-glycosylated proteins. Two different techniques were utilized to remove the non-glycosylated proteins from the glycoprotein solutions. Hydroxylapatite (HAUltrogel) chromatography in the presence of sodium dodecyl sulphate (SDS-HTP) did not separate the different HSV-1 glycoproteins and was not satisfactory for removing the non-glycosylated proteins. Gel-bound lectin affinity chromatography using wheat germ lectin and Helix pomatia lectin was not successful in purifying the glycoproteins because the glycoproteins which bound to the lectins could not be eluted under normal conditions. Difficulties encountered in eluting the HSV-1 glycoproteins from the lectins may have been due to the sodium dodecyl sulphate (SOS) in which the proteins were solubilized. For this reason, the gelbound lectin affinity chromatography was repeated using HSV-1 membrane proteins solubilized in a non-ionic detergent, Triton X-100. Using material prepared in this way, several HSV-1 glycoproteins were bound by wheat germ lectin and eluted under normal conditions to yield glycoproteins which were purified with respect to nonglycosylated proteins.
APA, Harvard, Vancouver, ISO, and other styles
8

Delboy, Mark. "PROTEASOME-DEPENDENT ENTRY OF HERPES SIMPLEX VIRUS." VCU Scholars Compass, 2010. http://scholarscompass.vcu.edu/etd/47.

Full text
Abstract:
Herpes simplex virus entry into cells is a multistep process that engages the host cell machinery. The proteasome is a large, ATP-dependent, multisubunit protease that plays a critical role in the maintenance of cell homeostasis. A battery of assays were used to demonstrate that proteasome inhibitors blocked an early step in herpes simplex virus entry that occurred after capsid penetration into the cytosol but prior to capsid arrival at the nuclear periphery. Proteasome-dependent viral entry was not reliant on host or viral protein synthesis. MG132, a peptide aldehyde that competitively inhibits the degradative activity of the proteasome, had a reversible inhibitory effect on herpes simplex virus capsid transport. Herpes simplex virus can use endocytic or nonendocytic pathways to enter cells. These distinct entry routes were both dependent on proteasome-mediated proteolysis. In addition, herpes simplex virus successfully entered cells in the absence of a functional host ubiquitin-activating enzyme, suggesting that viral entry is ubiquitin independent. Herpes simplex virus immediate-early protein ICP0 is a multifunctional regulator of herpes simplex virus infection. Late in infection ICP0 interacts dynamically with cellular proteasomes. ICP0 has a RING finger domain with E3 ubiquitin ligase activity that is necessary for its IE functions. The fundamental and functional properties of ICP0 that is present in the virion tegument layer have not been well characterized. For these reasons, I sought to characterize tegument ICP0 and determine the role of tegument ICP0 during proteasome-dependent entry of herpes simplex virus. Protein compositions of wild-type and ICP0 null virions were similar, suggesting that the absence of ICP0 does not grossly impair virion assembly. Virions with mutations in the RING finger domain contained greatly reduced levels of tegument ICP0, suggesting that the domain influences the incorporation of ICP0. Virion ICP0 was resistant to removal by detergent and salt and was associated with capsids, features common to inner tegument proteins. ICP0 mutations that resulted in the absence of ICP0 in the tegument layer, allow herpes simplex virus to enter cells independently of the proteasome activity. I propose that proteasomal degradation of virion and/or host proteins is regulated by ICP0 to allow for efficient delivery of incoming herpes simplex virus capsids to the nucleus.
APA, Harvard, Vancouver, ISO, and other styles
9

Dambrosi, Sarah. "Neurovirulence et latence des virus Herpes simplex mutants." Thesis, Université Laval, 2009. http://www.theses.ulaval.ca/2009/26368/26368.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Whiteley, Alison. "Studies of herpes simplex virus type-1 envelopment." Thesis, University of Cambridge, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621703.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Herpes simplex virus"

1

Rouse, Barry T., ed. Herpes Simplex Virus. Berlin, Heidelberg: Springer Berlin Heidelberg, 1992. http://dx.doi.org/10.1007/978-3-642-77247-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mindel, Adrian. Herpes Simplex Virus. London: Springer London, 1989. http://dx.doi.org/10.1007/978-1-4471-1683-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Diefenbach, Russell J., and Cornel Fraefel, eds. Herpes Simplex Virus. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0428-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Diefenbach, Russell J., and Cornel Fraefel, eds. Herpes Simplex Virus. New York, NY: Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4939-9814-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Brown, S. Moira, and Alasdair R. MacLean. Herpes Simplex Virus Protocols. New Jersey: Humana Press, 1997. http://dx.doi.org/10.1385/0896033473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

T, Rouse Barry, ed. Herpes simplex virus: Pathogenesis, immunobiology and control. Berlin: Springer-Verlag, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Tabery, Helen. Herpes Simplex Virus Epithelial Keratitis. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-642-01012-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Understanding herpes. Jackson: University Press of Mississippi, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stanberry, Lawrence R. Understanding herpes. Jackson, Miss: University Press of Mississippi, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Media, Springer Science+Business, ed. Herpes simplex virus: Methods and protocols. New York: Humana Press, 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Herpes simplex virus"

1

Aurelian, Laure. "Herpes Simplex." In Virus-Induced Immunosuppression, 73–100. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-5583-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Duroseau, Nathalie H., and Robyn R. Miller. "Herpes Simplex Virus." In Sexually Transmitted Infections in Adolescence and Young Adulthood, 235–54. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-20491-4_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gerstenblith, Adam T., and Tara Uhler. "Herpes Simplex Virus." In Encyclopedia of Ophthalmology, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-35951-4_94-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hall, Anthony. "Herpes Simplex Virus." In Atlas of Male Genital Dermatology, 83–85. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-99750-6_24.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lamps, Laura W. "Herpes Simplex Virus." In Surgical Pathology of the Gastrointestinal System: Bacterial, Fungal, Viral, and Parasitic Infections, 133–37. New York, NY: Springer US, 2009. http://dx.doi.org/10.1007/978-1-4419-0861-2_21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Armitage, Keith B. "Herpes Simplex Virus." In Encyclopedia of Women’s Health, 583–85. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-0-306-48113-0_195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Masterpol, Kasia Szyfelbein, Andrea Primiani, and Lyn McDivitt Duncan. "Herpes Simplex Virus." In Atlas of Essential Dermatopathology, 14–15. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-4471-4471-7_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gerstenblith, Adam T., and Tara Uhler. "Herpes Simplex Virus." In Encyclopedia of Ophthalmology, 855–57. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-540-69000-9_94.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kimberlin, David W. "Herpes Simplex Virus." In Congenital and Perinatal Infections, 63–72. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1385/1-59259-965-6:063.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schmid, D. Scott. "Herpes Simplex Virus." In Manual of Molecular and Clinical Laboratory Immunology, 550–55. Washington, DC, USA: ASM Press, 2016. http://dx.doi.org/10.1128/9781555818722.ch58.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Herpes simplex virus"

1

Mazurkov, O. Yu, М. D. Nekrasov, and A. S. Levina. "Antisense oligonucleotides against herpes simplex virus." In Новое поколение: достижения и результаты молодых ученых в реализации научных исследований. НИЦ "LJournal", 2023. http://dx.doi.org/10.18411/npdrmuvrni-11-2023-08.

Full text
Abstract:
The fight against herpesvirus infections is an urgent task because the herpes simplex virus (HSV) is very common among the human population and causes a wide range of diseases, ranging from relatively mild primary skin lesions to severe and often fatal episodes of encephalitis. The development of antisense technology with the use of antisense oligonucleotides (AO) is a promising step in this direction. To solve one of the main problems of delivering AO in cells, we prepared Si~NH2•AO nanocomplexes consisting of antisense oligonucleotides immobilized on aminosilanol nanoparticles as vehicles. Several nanocomplexes that contained AOs were tested for their activity against HSV-1, and two of them were shown to be the most efficient in inhibiting the virus replication by 2–2.5 orders of magnitude
APA, Harvard, Vancouver, ISO, and other styles
2

McManus, TE, AM Marley, N. Baxter, SN Christie, HJ O'Neill, JS Elborn, PV Coyle, and JC Kidney. "Herpes Simplex Virus and Mortality in COPD." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5348.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parchami, Ghazaee, Viktor Tumanov, and Hamed Rezayatmand. "NOVEL AGENTS FOR TREATMENT OF HERPES SIMPLEX VIRUS." In SCIENTIFIC PRACTICE: MODERN AND CLASSICAL RESEARCH METHODS. European Scientific Platform, 2021. http://dx.doi.org/10.36074/logos-26.02.2021.v3.41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cooper, J., K. Patel, and C. Richardson. "A Case of Severe Herpes Simplex Virus Pneumonitis." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a3584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chittal, A., K. Kumar, S. Rao, and M. Baydarian. "Herpes Simplex Virus 1 Meningitis Presenting as Status Epilepticus." In American Thoracic Society 2023 International Conference, May 19-24, 2023 - Washington, DC. American Thoracic Society, 2023. http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1743.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burke, S., A. Go, E. Charbek, S. Osmon, and P. Dinarvand. "Unusual Case of Herpes Simplex Virus Pneumonia in Immunocompetent Patient." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5205.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bilasco, Ancuta, Szidonia Florea, Ramona Cirt, Anca Draganescu, Magda Vasile, Camelia Kouris, Cristina Negulescu, and Monica Luminos. "GP45 Autoimmune encephalitis triggered by herpes simplex virus 1 infection." In Faculty of Paediatrics of the Royal College of Physicians of Ireland, 9th Europaediatrics Congress, 13–15 June, Dublin, Ireland 2019. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2019. http://dx.doi.org/10.1136/archdischild-2019-epa.111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sun, Liyuan, Limei Liu, Yundong Zhao, and Ming Yang. "The Effect of VHS Specific siRNA on Herpes Simplex Virus-1 Replication." In 2012 International Conference on Biomedical Engineering and Biotechnology (iCBEB). IEEE, 2012. http://dx.doi.org/10.1109/icbeb.2012.417.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

AL, Cunningham, M. Kim, Truong NR, Sandgren KJ, Harman AN, Bertram KM, L. Bosnjak, et al. "O06.2 Initial interactions of herpes simplex virus with human skin dendritic cells." In STI and HIV World Congress Abstracts, July 9–12 2017, Rio de Janeiro, Brazil. BMJ Publishing Group Ltd, 2017. http://dx.doi.org/10.1136/sextrans-2017-053264.31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kaufman, Stephen C., Jeffery A. Laird, and Roger W. Beuerman. "In-vivo immunofluorescence confocal microscopy of herpes simplex virus type 1 keratitis." In Photonics West '96, edited by Jean-Marie A. Parel, Karen M. Joos, and Pascal O. Rol. SPIE, 1996. http://dx.doi.org/10.1117/12.240044.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Herpes simplex virus"

1

Zhang, Xiaoliu. A Potent Oncolytic Herpes Simplex Virus for Therapy of Advanced Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2005. http://dx.doi.org/10.21236/ada442299.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Zhang, Xiaoliu. A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2005. http://dx.doi.org/10.21236/ada444233.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zhang, Xiaoliu. A Fusogenic Oncolytic Herpes Simplex Virus for Therapy of Advanced Ovarian Cancer. Fort Belvoir, VA: Defense Technical Information Center, June 2004. http://dx.doi.org/10.21236/ada426841.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Xiaoliu. A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate. Fort Belvoir, VA: Defense Technical Information Center, July 2006. http://dx.doi.org/10.21236/ada459160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhang, Xiaoliu. A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2004. http://dx.doi.org/10.21236/ada429083.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bertke, Andrea S. Influence of Herpes Simplex Virus Latency-Associated Transcript (LAT) on the Distribution of Latently Infected Neurons. Fort Belvoir, VA: Defense Technical Information Center, February 2007. http://dx.doi.org/10.21236/ad1013850.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lown, Rosemary. Investigations of Factors Affecting the Transcriptional Regulation of Herpes Simplex Virus Type 1 βγ (Leaky-Late) Genes. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.6731.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Liu, Xuehui. Studies on the Role of Cellular Factor, YY1, in Herpes Simplex Virus Type 1 Late Gene Expression. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.6732.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Chen, Shin. The DNA Sequence Required for the Maximal Transactivation of the VP5 Gene of Herpes Simplex Virus Type 1. Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.6600.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ye, Shanli. DNA Sequences Involved in the Regulation of Human c-myc Gene Expression by Herpes Simplex Virus Type 1 (HSV-1). Portland State University Library, January 2000. http://dx.doi.org/10.15760/etd.7097.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Herpes simplex virus' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography